Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) — Oct 4th, 2024

BRIDGEWATER, N.J., Oct. 4, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement ...

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 — Oct 17th, 2024

BRIDGEWATER, N.J., Oct. 17, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its t...

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 — Oct 17th, 2024

BRIDGEWATER, N.J., Oct. 17, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its t...

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now — Oct 6th, 2024

We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024.In this article, we are going to take a look at where Insmed Inc. (NASDAQ:INSM) stands against the other great performing NASDAQ stocks. Market Expectations for the Year-End Fed's recent cut has resulted in signi...

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains? — Oct 9th, 2024

Inovio Pharmaceuticals (INO) shares soared 6.8% in the last trading session to close at $5.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 16.9% loss over the past four weeks. The stock price rally can be a...

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 — Oct 17th, 2024

BRIDGEWATER, N.J., Oct. 17, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its t...

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results — Oct 8th, 2024

—Data Presented at the CHEST 2024 Annual Meeting— BRIDGEWATER, N.J., Oct. 8, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing seriou...

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Insmed (INSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might i...

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains? — Oct 9th, 2024

Inovio Pharmaceuticals (INO) shares soared 6.8% in the last trading session to close at $5.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 16.9% loss over the past four weeks. The stock price rally can be a...

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains? — Oct 9th, 2024

Inovio Pharmaceuticals (INO) shares soared 6.8% in the last trading session to close at $5.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 16.9% loss over the past four weeks. The stock price rally can be a...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) — Oct 4th, 2024

BRIDGEWATER, N.J., Oct. 4, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement ...

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains? — Oct 9th, 2024

Inovio Pharmaceuticals (INO) shares soared 6.8% in the last trading session to close at $5.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 16.9% loss over the past four weeks. The stock price rally can be a...

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 — Oct 17th, 2024

BRIDGEWATER, N.J., Oct. 17, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its t...

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains? — Oct 9th, 2024

Inovio Pharmaceuticals (INO) shares soared 6.8% in the last trading session to close at $5.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 16.9% loss over the past four weeks. The stock price rally can be a...

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 — Oct 17th, 2024

BRIDGEWATER, N.J., Oct. 17, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its t...

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results — Oct 8th, 2024

—Data Presented at the CHEST 2024 Annual Meeting— BRIDGEWATER, N.J., Oct. 8, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing seriou...

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 — Oct 17th, 2024

BRIDGEWATER, N.J., Oct. 17, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its t...

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now — Oct 6th, 2024

We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024.In this article, we are going to take a look at where Insmed Inc. (NASDAQ:INSM) stands against the other great performing NASDAQ stocks. Market Expectations for the Year-End Fed's recent cut has resulted in signi...

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now — Oct 6th, 2024

We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024.In this article, we are going to take a look at where Insmed Inc. (NASDAQ:INSM) stands against the other great performing NASDAQ stocks. Market Expectations for the Year-End Fed's recent cut has resulted in signi...

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Insmed (INSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might i...

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Insmed (INSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might i...

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 — Oct 17th, 2024

BRIDGEWATER, N.J., Oct. 17, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its t...

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results — Oct 8th, 2024

—Data Presented at the CHEST 2024 Annual Meeting— BRIDGEWATER, N.J., Oct. 8, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing seriou...

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Insmed (INSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might i...

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now — Oct 6th, 2024

We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024.In this article, we are going to take a look at where Insmed Inc. (NASDAQ:INSM) stands against the other great performing NASDAQ stocks. Market Expectations for the Year-End Fed's recent cut has resulted in signi...

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now — Oct 6th, 2024

We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024.In this article, we are going to take a look at where Insmed Inc. (NASDAQ:INSM) stands against the other great performing NASDAQ stocks. Market Expectations for the Year-End Fed's recent cut has resulted in signi...

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results — Oct 8th, 2024

—Data Presented at the CHEST 2024 Annual Meeting— BRIDGEWATER, N.J., Oct. 8, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing seriou...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) — Oct 4th, 2024

BRIDGEWATER, N.J., Oct. 4, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement ...

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Insmed (INSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might i...

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains? — Oct 9th, 2024

Inovio Pharmaceuticals (INO) shares soared 6.8% in the last trading session to close at $5.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 16.9% loss over the past four weeks. The stock price rally can be a...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) — Oct 4th, 2024

BRIDGEWATER, N.J., Oct. 4, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement ...

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now — Oct 6th, 2024

We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024.In this article, we are going to take a look at where Insmed Inc. (NASDAQ:INSM) stands against the other great performing NASDAQ stocks. Market Expectations for the Year-End Fed's recent cut has resulted in signi...

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now — Oct 6th, 2024

We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024.In this article, we are going to take a look at where Insmed Inc. (NASDAQ:INSM) stands against the other great performing NASDAQ stocks. Market Expectations for the Year-End Fed's recent cut has resulted in signi...

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now — Oct 6th, 2024

We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024.In this article, we are going to take a look at where Insmed Inc. (NASDAQ:INSM) stands against the other great performing NASDAQ stocks. Market Expectations for the Year-End Fed's recent cut has resulted in signi...

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 — Oct 17th, 2024

BRIDGEWATER, N.J., Oct. 17, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its t...

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Insmed (INSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might i...

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains? — Oct 9th, 2024

Inovio Pharmaceuticals (INO) shares soared 6.8% in the last trading session to close at $5.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 16.9% loss over the past four weeks. The stock price rally can be a...

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now — Oct 6th, 2024

We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024.In this article, we are going to take a look at where Insmed Inc. (NASDAQ:INSM) stands against the other great performing NASDAQ stocks. Market Expectations for the Year-End Fed's recent cut has resulted in signi...

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Insmed (INSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might i...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) — Oct 4th, 2024

BRIDGEWATER, N.J., Oct. 4, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement ...

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results — Oct 8th, 2024

—Data Presented at the CHEST 2024 Annual Meeting— BRIDGEWATER, N.J., Oct. 8, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing seriou...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) — Oct 4th, 2024

BRIDGEWATER, N.J., Oct. 4, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement ...

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results — Oct 8th, 2024

—Data Presented at the CHEST 2024 Annual Meeting— BRIDGEWATER, N.J., Oct. 8, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing seriou...

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results — Oct 8th, 2024

—Data Presented at the CHEST 2024 Annual Meeting— BRIDGEWATER, N.J., Oct. 8, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing seriou...

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Insmed (INSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might i...

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results — Oct 8th, 2024

—Data Presented at the CHEST 2024 Annual Meeting— BRIDGEWATER, N.J., Oct. 8, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing seriou...

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 — Oct 17th, 2024

BRIDGEWATER, N.J., Oct. 17, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its t...

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Insmed (INSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might i...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) — Oct 4th, 2024

BRIDGEWATER, N.J., Oct. 4, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement ...

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains? — Oct 9th, 2024

Inovio Pharmaceuticals (INO) shares soared 6.8% in the last trading session to close at $5.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 16.9% loss over the past four weeks. The stock price rally can be a...